Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wikström

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Nuclear Medicine and Biology|August 30, 2000
Radioligands for the study of brain 5-HT(1A) receptors in vivo--development of some new analogues of wayV W Pike, C Halldin, H Wikström, et al.
International Journal of Pharmaceutics|December 2, 2019
Robustness of a continuous direct compression line against disturbances in feedingA-P Karttunen, J Poms, S Sacher, et al.
European Journal of Nuclear Medicine|May 30, 1998
[carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivoV W Pike, C Halldin, J A McCarron, et al.
Journal of Medicinal Chemistry|September 23, 2000
Thiazoloindans and thiazolobenzopyrans: a novel class of orally active central dopamine (partial) agonistsL A van Vliet, N Rodenhuis, H Wikström, et al.
Journal of Medicinal Chemistry|August 24, 2000
Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907)L A van Vliet, N Rodenhuis, D Dijkstra, et al.
Nuclear Medicine and Biology|July 1, 1996
Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PETS Osman, C Lundkvist, V W Pike, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Nuclear Medicine and Biology|August 30, 2000
Radioligands for the study of brain 5-HT(1A) receptors in vivo--development of some new analogues of wayV W Pike, C Halldin, H Wikström, et al.
International Journal of Pharmaceutics|December 2, 2019
Robustness of a continuous direct compression line against disturbances in feedingA-P Karttunen, J Poms, S Sacher, et al.
European Journal of Nuclear Medicine|May 30, 1998
[carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivoV W Pike, C Halldin, J A McCarron, et al.
Journal of Medicinal Chemistry|September 23, 2000
Thiazoloindans and thiazolobenzopyrans: a novel class of orally active central dopamine (partial) agonistsL A van Vliet, N Rodenhuis, H Wikström, et al.
Journal of Medicinal Chemistry|August 24, 2000
Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907)L A van Vliet, N Rodenhuis, D Dijkstra, et al.
Nuclear Medicine and Biology|July 1, 1996
Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PETS Osman, C Lundkvist, V W Pike, et al.
Pageof 9